As generative AI reshapes browser usage, the acquisition will bring in-session browser security to the Falcon platform.
Bristol Myers Squibb (NYSE: BMY) today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback